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Abstract Myocardial normal databases for stress myo-
cardial perfusion study have been created by the Japanese
Society of Nuclear Medicine Working Group. The
databases comprised gender-, camera rotation range- and
radiopharmaceutical-speciﬁc data-sets from multiple insti-
tutions, and normal database ﬁles were created for instal-
lation in common nuclear cardiology software. Based
on the electrocardiography-gated single-photon emission
computed tomography (SPECT), left ventricular function,
including ventricular volumes, systolic and diastolic func-
tions and systolic wall thickening were also analyzed.
Normal databases for fatty acid imaging using
123I-beta-
methyl-iodophenyl-pentadecanoic acid and sympathetic
imaging using
123I-meta-iodobenzylguanidine were also
examined. This review provides lists and overviews of
normal values for myocardial SPECT and ventricular
function in a Japanese population. The population-speciﬁc
approach is a key factor for proper diagnostic and prog-
nostic evaluation.
Keywords Normal database  Myocardial
perfusion imaging  Systolic and diastolic function 
123I-BMIPP database 
123I-MIBG database
In nuclear cardiology, myocardial perfusion single-photon
emission computed tomography (SPECT) plays important
roles for diagnosis, guiding therapeutic strategies,
evaluation of therapeutic effects and in predicting future
cardiac events. Although recent technological advances in
cardiac imaging modalities are remarkable, nuclear cardi-
ology guidelines have been made in the United States and
Japan, and a large amount of evidence has supported the
use of radionuclide imaging in patients with acute syn-
dromes, chronic syndromes and heart failure [1, 2]. Prac-
tical approaches for speciﬁc populations have also been
recommended in nuclear cardiology guidelines.
The ﬁrst step of image-based diagnosis is careful visual
interpretation of myocardial images. Quantitative evalua-
tion using myocardial perfusion imaging, however, aids
diagnostic accuracy and enhances diagnostic certainty by
reducing borderline interpretations. Various software
programs have been developed, and more sophisticated
and user-friendly approaches have been under develop-
ment [3–5]. Common quantitative features of these soft-
ware programs included calculating myocardial count on
SPECT slices using appropriate segmentations and dis-
playing the quantitative values on polar maps or three-
dimensional surface maps. In the processing algorithm,
individual patient data were compared with control data-
bases from low likelihood of heart diseases. Therefore,
characteristics of the standard database might have
inﬂuenced the ﬁnal diagnostic accuracy. The Japanese
Society of Nuclear Medicine (JSNM) database was cre-
ated as a working group activity from these background
studies [6].
To diagnose Japanese patients, it is necessary to use a
normal Japanese database—this is a simple assumption.
However, is it actually critical for the diagnosis? In this
review, we deal with this question and summarize the
characteristics of the Japanese databases for myocardial
perfusion, fatty acid imaging and sympathetic imaging. In
addition, characteristics of left ventricular function based
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Myocardial perfusion database
Myocardial perfusion imaging with either exercise or
pharmacological stress provides fundamental information
for diagnosis of ischemic heart diseases, and its clinical
utility has been established based on nearly three decades
of experience. Although an individual institution-speciﬁc
normal database may best ﬁt the acquisition method and
study population, accumulating and validating normal
databases usually require cumbersome steps. The major
merit of the authorized common databases, if they are
available, is that they can be safely used in most of the
institutions where standard acquisition and stress protocols
are used. In the working group activity involving multiple
nuclear medicine centers; however, we could not add all
our raw data into one common database. Considering the
factors that inﬂuenced regional myocardial distribution, we
separated databases by genders, 360 and 180 rotation
acquisitions, and
201Tl and
99mTc pharmaceuticals.
Because
99mTc-tetrofosmin and
99mTc-methoxy-isobutyl
isonitrile (MIBI) showed no statistical differences in tracer
distribution by preliminary investigation, both
99mTc data
types were added.
Nine hospitals collaborated on the normal database
accumulation, and a total of 326 sets of exercise–rest
myocardial perfusion images were accumulated from sub-
jects with a low likelihood of cardiac diseases [6]. Using a
DICOM (digital imaging and communications in medicine)
format, projection images with gated and non-gated studies
were anonymously transferred to the core laboratory of
Kanazawa University. The reconstruction parameters for
SPECT images were standardized and processed using the
same computer (GE Yokogawa Medical Systems, Co, Ltd,
Tokyo, Japan). The following software was available:
QGS-QPS (Cedars-Sinai Medical Center, Los Angeles,
CA, USA), Emory’s Cardiac Toolbox (Emory University,
Atlanta, GA, USA) and 4D-MSPECT (University of
Michigan Medical Center, Ann Arbor, MI, USA).
Although we have created standard database ﬁles for each
software program, all the quantitative analyses written in
this article are based on the QPS-QGS algorithm of
quantiﬁcation.
Figure 1 shows polar maps created by a normal Japa-
nese population. When the 360 and 180 rotation methods
were compared, septal segments showed higher values in
the 180 rotation for both
99mTc and
201Tl. Differences in
genders were signiﬁcant in the mid- and apical inferior
segments showing lower values in men due to diaphrag-
matic attenuation. In females, apical anterior segments
showed lower values due to breast attenuation. Differences
between
201Tl and
99mTc tracers were not negligible [6].
When the normal databases from the United States
(Cedars-Sinai Medical Center database pre-installed in the
standard QPS) and Japan were compared, attenuation in the
anterior wall was greater in the American female popula-
tion than in the Japanese population. Inferior diaphragmatic
attenuation was greater in the American population in
males. Does the small difference between nations actually
inﬂuence the diagnostic accuracy? The diagnostic perfor-
mance was evaluated by receiver-operating characteristic
analysis among Japanese 360 and 180 acquisition dat-
abases (Jp360 and Jp180) and an American database with a
180 acquisition database (US180), when Japanese patients
with a 360 acquisition method were analyzed [7]. Areas
under the curve were the highest for Jp360 (0.842), fol-
lowed by Jp180 (0.758) and US180 (0.728) databases
(P = 0.019, Jp360 vs. US180; P = 0.035, Jp360 vs.
Jp180). Because of the database difference in the inferior
wall of male patients, diagnostic improvement was dem-
onstrated in the right coronary artery territory (Fig. 2).
Similarly, differences in the anterior wall in female patients
resulted in improved accuracy in left anterior descending
coronary territory. Thus, it was essential to use population-
and acquisition-speciﬁc databases when using quantitative
perfusion SPECT software. Clinical validation was subse-
quently performed when the same database could be used
in various types of software and versions [8]. Five insti-
tutions participated in the study, and each used different
acquisition settings that included 360 and 180 rotation
ranges, camera conﬁgurations and camera orbits. The core
laboratory created normal database ﬁles from the original
JSNM short-axis image sets, which were ﬁtted for each
software version. Overall sensitivity, speciﬁcity and accu-
racy of patient-based analysis were 77, 72 and 75%,
respectively, based on the quantitative analysis using the
common database, whereas those by institutional visual
expert reading were 72, 79 and 75%, respectively.
Although the diagnostic accuracy was moderately good,
the study indicated that the common database could be
applicable to different institutions when such a database
was appropriately created according to the software-
speciﬁc database generator.
Left ventricular function in a Japanese population
A number of studies have demonstrated that gated SPECT
evaluation of ejection fraction (EF), regional wall motion
and wall thickening was accurate, and gated SPECT could
be considered as an effective substitute modality of
radionuclide ventriculography for the assessment of left
ventricular function [9–12]. Although the reproducibility of
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123Fig. 1 Polar map presentation of normal myocardial SPECT
databases using a 17-segment model. Average segmental values are
overlaid on the maps. Upper two panels stress and rest perfusion
studies with
99mTc-labeled tracers (MIBI and tetrofosmin) and
201Tl
using 180 and 360 acquisition methods. Lower two panels
123I
BMIPP and
123I MIBG studies with 180 and 360 acquisition
methods
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123QGS software was evaluated well regarding inter-observer
variability, the precision of EF and left ventricular volume
determination was further conﬁrmed in the multicenter
J-ACCESS investigation [13, 14]. The reproducibility or
precision of EF was good in 106 hospitals, showing a
standard deviation of \3.6%, and the coefﬁcient of vari-
ance of the end-diastolic volume was \9.3% in all cases.
However, it has also been noticed that if American and
European standard values are used, the normal values were
not always appropriate for a Japanese population in clinical
practice [15–18]. In fact, when a certain threshold value
was used for discriminating abnormal patients or estimat-
ing cardiac event risks, it may have been potentially
misleading for patient care. The normal values of left
ventricular function calculated in a Japanese population are
shown in Table 1, which are derived from the JSNM
working group study. The calculated EF value was higher
for women than in men in Japanese populations for both
JSNM database and J-ACCESS prognostic database
(Table 2)[ 6, 19]. This is not simply because of under-
estimation of volume and overestimation of EF in small
hearts due to an algorithm of edge tracing by QGS software
[20, 21]. A magnetic resonance imaging (MRI) study also
demonstrated that women had a higher left ventricular EF
than men in the general population of Dallas County resi-
dents aged 30–65 years (1435 women, 1183 men) [22]. A
low left ventricular EF was deﬁned as below 61% in
women and below 55% in men by MRI, and the difference
between genders was comparable for our gated SPECT
studies. In a Japanese population, mean female EF was
higher when compared with that of American and Euro-
pean populations, which seemed to reﬂect smaller body
size in Japanese women (Table 2). The lower borders of EF
can be deﬁned as below *55% in women and below
*50% in men using gated SPECT.
The diastolic function determined for the Japanese
population using a 16-frame format is summarized in
Table 1 Normal values of left ventricular function by gated SPECT
based on 16-frame gated SPECT with
99mTc-MIBI and tetrofosmin
JSNM WG database Males Females
Number of subjects 49 35
Age (years)
Mean ± SD 58.3 ± 13.0 55.6 ± 13.7
EF (%)
Mean ± SD 65.6 ± 5.9 71.0 ± 7.3
Mean - 2SD 53.8 56.4
Mean ? 2SD 77.4 85.6
EDV (mL)
Mean ± SD 82.3 ± 16.3 67.4 ± 13.1
Mean - 2SD 49.7 41.2
Mean ? 2SD 114.9 93.6
ESV (mL)
Mean ± SD 28.7 ± 9.0 20.1 ± 7.9
Mean - 2SD 10.7 4.3
Mean ? 2SD 46.7 35.9
EDVI (mL/m
2)
Mean ± SD 49.0 ± 8.0 42.3 ± 5.9
Mean - 2SD 33.0 30.5
Mean ? 2SD 65.0 54.1
ESVI (mL/m
2)
Mean ± SD 17.1 ± 4.8 12.6 ± 4.0
Mean - 2SD 7.5 4.6
Mean ? 2SD 26.7 20.6
Small heart (ESV\20 mL) 22% 51%
JSNM WG Japanese Society of Nuclear Medicine Working Group, EF
ejection fraction, EDV end-diastolic volume, ESV end-systolic vol-
ume, EDVI EDV index, ESVI ESV index Fig. 2 Regional summed stress scores determined by Japanese 180
and 360 databases (Jp180, Jp360) and an American 180 database
(US180). The normal database was applied to a Japanese patient
group (n = 90) with a 360 acquisition [7]. a Regional scores in the
right coronary artery (RCA) territory in males. b Those in the left
anterior descending coronary artery (LAD) territory in females. A
P value in each bar is indicated in comparison with US180 database
128 Ann Nucl Med (2010) 24:125–135
123Table 3 using the JSNM database with two previously
published studies [18, 23]. Although a 32-frame division of
a cardiac cycle might provide better correlation with those
determined by radionuclide ventriculography [24, 25], a
more practical approach seems to be a 16-frame acquisition
per RR interval, when considering the counting statistics of
the myocardial activity. Using QGS software algorithm,
abnormal thresholds in the American population included
peak ﬁlling rate (PFR)\1.70 per s and time to PFR (TTPF)
[208 ms [18]. Multivariable analysis showed that age,
sex, EF and heart rate were strong predictors for PFR,
whereas TTPF was not inﬂuenced by any clinical or
systolic function variables. The Japanese population
also showed comparable normal values (Table 3). When
patients were classiﬁed into two age groups of \60 and
C60 years, standard deviations of PFR, 1/3 mean ﬁlling
rate, TTPF and TTPF/RR were larger in the older group
than in the younger group. Because age-related differences
were observed, it should be kept in mind that diastolic
dysfunction in elderly patients and in those with EF\50%
are more common [26]. Large population-based criteria,
adjusted for age and sex, for normal versus abnormal dia-
stolic function have not yet been established. Therefore,
when the severity of diastolic dysfunction has become
increasingly important in patients with the clinical syn-
drome of heart failure, the validity of diastolic function
should be more extensively evaluated with nuclear meth-
ods [1].
To evaluate left ventricular regional wall motion, wall
thickening seemed to be more appropriate for gated
SPECT. When wall motion deﬁned by endocardial
perimeter was used (unit of mm), septal motion was rela-
tively low when compared with that of free walls. The
postoperative heart typically showed decreased motion
even when septal systolic wall thickening (unit of %) was
preserved [27–29]. Therefore, we recommend the use of
thickening map for evaluating regional asynergy. Normal
values of wall thickening were evaluated from a total of
202 patients in the JSNM database [30]. In any acquisition
protocol, myocardial wall thickening in the apex was
higher than that in the mid and basal regions. Different
rotation angles showed no signiﬁcant change on wall
Table 2 Comparison of normal values of left ventricular function by QGS software
Males Females
Mean ± SD Mean - 2SD Mean ? 2SD Mean ± SD Mean - 2SD Mean ? 2SD
De Bondt (43 M, 59 F) [16]
EF (%) 59 ± 64 7 7 1 6 6 ± 94 8 8 4
EDV (mL) 106 ± 25 56 156 75 ± 23 29 121
ESV (mL) 44 ± 14 16 72 27 ± 14 -15 5
EDVI (mL/m
2)5 4 ± 14 26 82 43 ± 11 21 65
ESVI (mL/m
2)2 3 ± 8 7 39 16 ± 72 3 0
Ababneh (116 M, 124 F) [17]
EF (%) 62 ± 74 8 7 6 6 7 ± 85 1 8 3
EDV (mL) 74 ± 22 30 118 57 ± 17 23 91
ESV (mL) 29 ± 13 3 55 19 ± 11 -34 1
EDVI (mL/m
2)3 8 ± 92 0 5 6 3 2 ± 81 6 4 8
ESVI (mL/m
2)1 5 ± 6 3 27 10 ± 50 2 0
J-ACCESS (119 M, 149 F) [14]
EF (%) 63 ± 74 9 7 7 7 4 ± 95 6 9 2
EDV (mL) 88 ± 23 44 132 59 ± 17 25 93
ESV (mL) 33 ± 13 7 59 17 ± 10 -33 7
EDVI (mL/m
2)5 1 ± 12 27 75 39 ± 11 17 61
ESVI (mL/m
2)1 9 ± 7 5 33 11 ± 6 -12 3
JSNM WG (68 M and 68 F) [6]
a
EF (%) 64 ± 75 0 7 8 6 9 ± 75 4 8 4
EDV (mL) 80 ± 16 49 112 64 ± 13 39 90
ESV (mL) 29 ± 91 2 4 7 2 0 ± 77 3 4
EDVI (mL/m
2)4 7 ± 93 0 6 4 4 2 ± 72 9 5 5
ESVI (mL/m
2)1 7 ± 5 8 27 13 ± 45 2 2
M males, F females
a Both data from 180 and 360 rotation acquisition methods are added
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123thickening, but different frame rates and tracers showed
signiﬁcant differences in both genders. The higher wall
thickening in women than in men was comparable to
ﬁndings of the higher EF in women. Because wall thick-
ening has not been used separately depending on the
acquisition protocol and gender differences so far, appro-
priate database construction might be required. Because
wall thickening was relatively uniform in the six basal
segments, six mid segments and four apical segments in
each gender, practical threshold values are shown in
Table 4 using 16-frame gated SPECT with both 360 and
180 acquisition methods added. For males, approximate
lower borders of wall thickening are 30, 40 and 50% for
mid, apical and apex segments, respectively. For females,
they were 35, 45 and 55% for mid, apical and apex seg-
ments, respectively.
Normal database for I-123 BMIPP fatty acid imaging
In clinical practices in Japan, where BMIPP is approved by
the Health, Labor and Welfare Ministry and covered by
health insurance, normal myocardial
123I-BMIPP databases
Table 3 Normal values of diastolic parameters using 16-frame gated SPECT
JSNM WG Nakajima [23] Akincioglu [18]
All \60 years C60 years Control group All
Number of subjects 60 33 27 16 90
Age (mean ± SD) 58 ± 15 48 ± 11 70 ± 65 0 ± 12 53 ± 11
Heart rate (per min) (mean ± SD) 66 ± 12 66 ± 11 65 ± 13 65 ± 77 4 ± 8
Peak ﬁlling rate (per s)
Mean ± SD 2.69 ± 0.57 2.79 ± 0.53 2.58 ± 0.60 2.46 ± 0.45 2.62 ± 0.46
Mean - 2SD 1.55 1.73 1.38 1.56 1.70
Mean ? 2SD 3.83 3.85 3.78 3.36 3.54
1/3 mean ﬁlling rate (per s)
Mean ± SD 1.60 ± 0.39 1.68 ± 0.30 1.51 ± 0.47 1.52 ± 0.25
Mean - 2SD 0.82 1.08 0.57 1.02
Mean ? 2SD 2.38 2.28 2.45 2.02
Time to peak ﬁlling (ms)
a
Mean ± SD 167 ± 38 159 ± 26 176 ± 48 166 ± 22 165 ± 22
Mean - 2SD 91 108 80 122 121
Mean ? 2SD 243 210 273 210 208
Time to peak ﬁlling/RR interval
Mean ± SD 0.18 ± 0.03 0.17 ± 0.02 0.18 ± 0.04 0.18 ± 0.02
Mean - 2SD 0.12 0.13 0.11 0.14
Mean ?2 SD 0.24 0.22 0.26 0.22
Ejection fraction (%)
Mean ± SD 68 ± 66 7 ± 76 9 ± 76 8 ± 96 4 ± 6
a Time to peak ﬁlling is deﬁned as time from end systole to PFR
Table 4 Normal values of wall thickening (%) using 16-frame gated
SPECT
Males Females
Number of subjects 36 33
Six basal segments
Mean ± SD 24.7 ± 9.5 25.1 ± 9.4
Mean - 2SD 5.7 6.2
Mean ? 2SD 43.8 43.9
Six mid segments
Mean ± SD 47.2 ± 9.2 53.0 ± 9.1
Mean - 2SD 28.8 34.8
Mean ? 2SD 65.5 71.3
Four apical segments
Mean ± SD 62.6 ± 10.5 69.1 ± 11.3
Mean - 2SD 41.7 46.5
Mean ? 2SD 83.5 91.7
An apex segment
Mean ± SD 74.2 ± 12.1 77.5 ± 12.1
Mean - 2SD 50.0 53.4
Mean ? 2SD 98.4 101.7
Both data from 180 and 360 rotation acquisition methods are added
[30]
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123have not been deﬁned and utilized. Japanese nuclear
cardiology guidelines approved fatty acid imaging with
respect to indications for acute coronary syndromes
and repeated ischemic episodes in chronic syndromes
[2, 31–33]. Common ﬁndings included perfusion and
metabolic mismatch, suggesting temporary metabolic
deterioration in the viable myocardium. The BMIPP
accumulation reﬂected a risk area after acute myocardial
infarction and perfusion defect reﬂected myocardial
infarction [34]. Although comparison between perfusion
and metabolism is essential, an appropriate normal data-
base would contribute to enhanced diagnostic accuracy.
Owing to small, but signiﬁcant differences between
99mTc
perfusion tracer and
123I-BMIPP existed, the use of com-
mon databases would be helpful for accurate diagnosis
[35]. In the
123I-labeled tracer databases, only 360 data-
sets were available. As a result, 180 databases were made
tentatively using a left anterior 180 arc of the whole
rotation range (Fig. 1).
Normal database for I-123 MIBG sympathetic imaging
According to nuclear cardiology guidelines by the Japanese
CirculationSociety,
123I-MIBGcontainsclinicalindications
for heart failure particularly for evaluating severity, thera-
peutic effects and prognosis of heart failure [2, 36–38].
UsingMIBGuptakeindices,aquantitativethresholdforlow
risk of cardiac mortality and potentially fatal ventricular
arrhythmias might be identiﬁed [39]. In addition, the MIBG
study showed markedly decreased myocardial uptake in
Parkinson’s disease, dementia with Lewy bodies (DLB) and
pureautonomicfailure,whichisacommonfeatureofLewy-
body diseases [40–43]. In the report of the Consortium on
DLBInternationalWorkshop,theMIBGstudywasincluded
as one of the supportive features of DLB [44]. To quantify
MIBG uptake, heart to mediastinal average count (H/M)
ratio has been used as a simple method that could be used in
any institutes [45]. However, lack of standardization ham-
perslarge-scaleimplementationof
123I-MIBGparametersin
the evaluation of patients with chronic heart failure [46, 47].
Inparticular,achoiceofcollimatorswas animportantfactor
of quantitative variations. Thus, the JSNM database also
aimed at creating a normal database for planar anterior
images as well as SPECT imaging.
A number of MIBG studies have used the H/M ratio as a
practical method for quantiﬁcation. When low-energy
collimators were used, the average H/M ratios were around
2.1–2.4, with the lower cutoff values around 1.6–2.0 [48].
In contrast, if medium-energy or low-medium-energy
collimators were used, the average values were around
2.8–3.0. The H/M ratio accumulated from the JSNM
working group is summarized in Table 5. According to a
questionnaire survey conducted in Japan, normal H/M
ratios using a low-energy high-resolution collimator and a
medium-energy collimator were comparable to those of the
JSNM database [49]. Signiﬁcant differences were found
between H/M values from data using both collimators. To
standardize H/M ratios, some attempts have been pre-
sented, such as use of medium-energy collimators [50],
deconvolution of septal penetration [51] and multiple-
window or iodine-123 dual energy window (IDW) methods
[48, 52]. When the IDW method was used with a calibra-
tion phantom and in clinical studies, corrected H/M values
with a low-energy collimator became comparable to that of
a medium-energy collimator. A method for stabilizing the
location of the region of interest should also be investi-
gated. Further studies are required to determine whether
this type of correction can truly enhance diagnostic ability,
and whether they may be used for multicenter studies.
Three-dimensional MIBG distribution seemed to be
heterogeneous based on a SPECT study [53]. The sympa-
thetic nervous system in the human left ventricle showed
age- and gender-related regional changes [54]. In clinical
practice, a decrease in MIBG uptake in the inferolateral
walls has sometimes been observed particularly in elderly
patients, but individual differences in segmental uptake
have also been observed. In accordance with this ﬁnding,
Table 5 Normal values of I-123 MIBG heart to mediastinum ratio
LE collimator ME or LME
collimator
JSNM WG data
Number of patients 36 20
Early H/M ratio
Mean ± SD 2.39 ± 0.21 2.76 ± 0.31
Mean - 2SD 1.97 2.14
Mean ? 2SD 2.81 3.38
Delayed H/M ratio
Mean ± SD 2.49 ± 0.25 3.01 ± 0.35
Mean - 2SD 1.99 2.31
Mean ? 2SD 2.99 3.71
Questionnaire survey in Japan [47]
Number of institution 15 2
Early H/M ratio
Mean ± SD 2.25 ± 0.27 2.78 ± 0.32
Mean - 2SD 1.71 2.14
Mean ? 2SD 2.79 3.42
Delayed H/M ratio
Mean ± SD 2.36 ± 0.24 3.17 ± 0.29
Mean - 2SD 1.88 2.59
Mean ? 2SD 2.84 3.75
LE low energy, ME medium energy, LME low-medium-energy,
H/M heart to mediastinum
Ann Nucl Med (2010) 24:125–135 131
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activity in the inferior, which was more prominent in the
delayed image (Fig. 1). The deviation of the apical inferior
wall is relatively increased. Although it is conceivable that
age-related changes inﬂuenced count distribution, we could
not make age-speciﬁc standards because of the limited
number of normal patients.
Cardiovascular event risk
Quantiﬁcation of abnormal perfusion defect or induced
ischemia serves to enhance diagnostic accuracy and patient
risk stratiﬁcation. For estimating patient prognosis, semi-
quantitative evaluation of summed score of stress, rest and
difference are powerful predictors of hard and all events, in
additiontobeingfactorsofbaselineleftventricularfunction.
The evidence-based role of scoring has been employed for
risk evaluation in patients suspected of having ischemic
heart disease. The Japanese multicenter prognostic cohort
study (J-ACCESS prognostic database) demonstrated that a
stress myocardial perfusion study with gated SPECT could
provide effective prognostic information, although the hard
eventratewasrelativelylowerinaJapanesepopulation[55–
57]. In fact, according to the governmental statistics, the
mortality rate caused by cardiac diseases in Japan is one of
the lowest in the world compared with that of American and
European countries. The rate is about one-third that of the
US. Nevertheless, normal and severely abnormal summed
stress score values were associated with low (2.3%/3 years)
and high (9.2%/3 years) rates of major cardiac events,
including cardiac death, non-fatal myocardial infarction
and severe heart failure. Rates of major cardiac events
were signiﬁcantly higher in patients with EF\45% than in
those with EF C 45% (16.6 vs. 2.9%/3 years; P\0.001).
Although a precise description for the event risk is not the
aim of this article, risk evaluation based on the Japanese
databases and ethnic background would be essential for
effective patient management.
Future directions
The characteristics of normal databases depend on tech-
nological advances in SPECT. Several attempts have been
performed to improve attenuation, scatter and resolution
corrections [58, 59]. Attenuation correction might enable
the use of a single gender-independent normal database and
a single criterion for abnormality. However, attenuation
correction seems to provide different effects based on
the imaging system used [60]. The prone positioning
was also used to compensate for attenuation artifacts
[61, 62]. Attenuation correction of myocardial SPECT by
scatter-photopeak window method was also investigated
[63]. Because myocardial count distribution in normal
subjects does not show complete homogeneity with any
methods, some kind of additional database matched with
advanced technological capability would be required.
Moreover, a validation study to determine appropriate
cutoff values between normal and abnormal groups should
be investigated. With the recent advances of fusion tech-
nology using X-ray computed tomography angiography
and myocardial perfusion imaging, functional relevance to
coronary stenosis could be enhanced [64–66]. Quantitative
accuracy would be further improved by anatomical
and functional correlations using appropriate normal
databases.
Conclusions
The JSNM normal databases were the ﬁrst databases
authorized by the scientiﬁc society. The mixture of typical
acquisition condition from different institutions has merits
for applying the same database to a multicenter study and
to inter-institution comparison of the SPECT results.
Although an institution-speciﬁc database created in every
institution would be theoretically desirable, a common
database could be a practical approach for clinical evalu-
ation of patients suspected of having coronary artery dis-
eases. Finally, normal values derived from a common
database could be applied in clinical studies with respect to
myocardial perfusion, left ventricular systolic and diastolic
function, fatty acid imaging and sympathetic imaging.
Appendix
Participating hospitals and researchers for database
accumulation
Chief of the working group: Kenichi Nakajima (Kanazawa
University), Koichi Okuda, Shinro Matsuo*, Tatsuya
Yoneyama, Junichi Taki* (Kanazawa University Hospital),
Shinichiro Kumita*, Yoshimitsu Fukushima (Nippon
Medical School Hospital), Yoshio Ishida* (National Car-
diovascular Center), Jun Hashimoto* (Keio University
Hospital, Tokai University at present), Mitsuru Momose*
(Tokyo Women’s Medical University), Koichi Morita*,
Masayuki Inubushi, Keiichiro Yoshinaga* (Hokkaido
University Hospital), Shohei Yamashina* (Toho University
Omori Medical Center), Hirotaka Maruno* (Toranomon
Hospital), Naoya Matsumoto* (Nihon University School of
Medicine), Masaya Kawano* (Kanazawa Cardiovascular
Center), Kazuyuki Sakata (Shizuoka Cancer Center),
*JSNM working group member.
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123Cooperation for creating normal databases
Guido Germano, Piotr Slomka, Geoff Pollard (Cedars-
Sinai Medical Center, USA), Ernest Garcia (Emory Uni-
versity Hospital, USA), Edward Ficaro (University of
Michigan Medical Center, USA).
Cooperating companies
GE Yokogawa Medical Systems (Tokyo, Japan), Toshiba
Medical Systems Corporation (Tokyo, Japan), Siemens-
Asahi Medical Technologies (Tokyo, Japan), Hitachi
Medical Corporation (Tokyo, Japan), Shimadzu Corpora-
tion (Kyoto, Japan), FUJIFILM RI Pharma (Tokyo, Japan),
Nihon Medi-Physics (Tokyo, Japan).
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